Home

Can OSD Handle the GLP-1 Appetite?
The injectable weight-loss drug boom didn’t just strain drugmakers with approved products, it reshaped the entire pharma ecosystem, forcing suppliers and manufacturers to reorganize around GLP-1s. read more
Oral Solid Dose Regulatory Approval Update
CDER has approved 33 novel drugs so far, almost half of which are oral solid dose formulations. read more
Root Cause Analysis of Tablet Manufacturing Issues
Many formulation challenges such as poor flow, segregation, capping and weak tablets can be traced to suboptimal micromeritics properties. read more
Creating Amorphous Solid Dispersions via Spray Drying
Spray-dried ASDs are increasingly used to improve bioavailability for complex new molecules, making efficient process development tools and methodologies essential for accelerating commercialization. read more

Lilly Breaks Ground on $6.5B Houston API Site for Foundayo
September 24, 2026
The site is one of ten U.S. manufacturing sites announced since 2020. read more
Bayer’s Kerendia Wins First T1D CKD Treatment Nod in 30 Years
September 21, 2026
The oral drug is expected to reduce the risk of eGFR decline and end-stage kidney disease. read more
Lilly Wins Expanded Approval for Oral SERD for Use in Breast Cancer Combo
September 21, 2026
This marks the second FDA approval for Inluriyo in less than a year, following its September 2025 approval as a monotherapy. read more